Pioglitazone lowered plasma insulin ( P < 0.001 ) , improved insulin sensitivity ( P < 0.001 ) , increased HDL ( P < 0.001 ) , and reduced triglycerides ( P = 0.003 ) , free fatty acids ( P = 0.005 ) , and C-reactive protein ( P = 0.001 ) .